Eperezolid is primarily used as an antibacterial agent, particularly effective against Gram-positive bacteria. It is often employed in the treatment of infections caused by resistant strains, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). Its application extends to complicated skin and soft tissue infections, where traditional antibiotics may fail. Additionally, eperezolid is utilized in clinical settings for patients who have shown intolerance or lack of response to other antibiotic treatments. Eperezolid exerts its effect by inhibiting bacterial protein synthesis, preventing bacterial growth and proliferation. Its role in combating multidrug-resistant infections makes it a valuable component in the arsenal of modern antimicrobial therapy. Use of eperezolid should be under close medical supervision to prevent side effects and other risks.